15 May 2018

On the occasion of the retirement of Bé Wieringa a farewell symposium and valedictory lecture will be organized on the 1st of June.



The symposium Journey of a lifetime will be organized in honour of Bé Wieringa’s retirement, preceding his valedictory lecture.

Bé Wieringa (Delfzijl, 1951) studied Chemistry at the University of Groningen, where he also did his PhD on genes and mRNAs of chicken yolk proteins (with Prof. M. Gruber). He moved to the ETH in Zürich for a postdoc in Charles Weissmann's lab on Globin RNA splicing. In 1984, he joined the Human Genetics department at Radboud University and started his life-long work on disease mechanisms underlying myotonic dystrophy. He was appointed professor in Cell Biology in 1990 and became head of the department of Cell Biology. Bé Wieringa initiated the generation of mouse models for human diseases, using gene targeting in mouse embryonic stem cells, in Nijmegen and was one of the co-founders of the RIMLS (NCMLS at the time).

During his career Bé Wieringa received many grants and awards.
1969 Chemie Studieprijs, RUG
1983 Nederlandse Vereniging voor Biochemie en Moleculaire Biologie Prijs
2011 Universitaire Onderwijsprijs, Radboud University
2013 Lifetime Achievement Award, Myotonic Dystrophy Foundation (USA)
2013 Trajectory in Basic Research in Myotonic Dystrophy Award, International Myotonic Dystrophy Consortium

Related news items


More variants TLR7 gene found in young healthy men with severe Covid-19 Screening and accelerated vaccination for TLR7 immunodeficiency

3 August 2021 Spanish-Dutch research has revealed two new mutations in the TLR7 gene in healthy young men who became seriously ill with severe Covid-19. read more

Sonlicromanol seems promising for certain cancers Khondrion announces publication in PLOS ONE of new research

13 July 2021 Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite. read more

Current overview of intriguing RNA therapies

8 April 2021 In an article in EMBO Molecular Medicine, researchers from Radboudumc, together with European colleagues, provide an up-to-date overview of the (im)possibilities of these intriguing RNA therapies. read more

Final scientific pitch competition Radboud Talks

14 March 2019 The finalists of the scientific pitch competition Radboud Talks have been selected. On Monday evening 25 March, eight scientists will compete in LUX for the award. read more

TURBO grants for four medical-technical research projects

8 November 2018 Four TURBO grants were awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between Radboudumc and the University of Twente. read more